TCG Crossover (TCG X) has raised an inaugural $824 million fund on crossover and public investments in the life sciences.
Investors in the oversubscribed fund include the Texas County & District Retirement System, other pensions funds, university endowments, family offices and sovereign wealth funds.
TCG X invests exclusively in innovative drug discovery companies that are seeking the make an impact on unmet medical needs. The firm is led by Dr. Chen Yu, formerly a . . .
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.